S.2012 - Designer Anabolic Steroid Control Act of 2014113th Congress (2013-2014)
|Sponsor:||Sen. Whitehouse, Sheldon [D-RI] (Introduced 02/11/2014)|
|Committees:||Senate - Judiciary|
|Latest Action:||02/11/2014 Read twice and referred to the Committee on the Judiciary. (All Actions)|
|Notes:||For further action, see H.R.4771, which became Public Law 113-260 on 12/18/2014.|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Subject — Policy Area:
- Crime and Law Enforcement
- View subjects
Summary: S.2012 — 113th Congress (2013-2014)All Bill Information (Except Text)
Introduced in Senate (02/11/2014)
Designer Anabolic Steroid Control Act of 2014 - Amends the Controlled Substances Act to: (1) expand the list of substances defined as "anabolic steroids"; (2) authorize the Attorney General to issue a temporary order adding a drug or other substance to the list of anabolic steroids; (3) impose enhanced criminal and civil penalties for possessing or trafficking in any anabolic steroid, or product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry; and (4) authorize the Attorney General to collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled.
Specifies that a substance shall not be considered to be a drug or hormonal substance that is considered to be an anaboloic steroid if it is: (1) an herb or other botanical; (2) a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical; (3) a combination of two or more such substances (i.e., botanical or concentrate, metabolite, or extract); or (4) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act. Provides that any person claiming the benefit of an exemption or exception from being considered a drug or hormonal substance shall bear the burden of providing the appropriate evidence.
Directs: (1) the United States Sentencing Commission to review and amend federal sentencing guidelines with respect to offenses involving anabolic steroids, and (2) the Administrator of the Drug Enforcement Administration (DEA) to report every two years on what anabolic steroids have been scheduled on a temporary basis under this Act.